Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Entero Therapeutics ( (ENTO) ).
On June 30, 2025, Entero Therapeutics, Inc. held its Annual Meeting of Stockholders, where all five proposals were approved. The stockholders elected five directors to the board for a one-year term and approved a potential reverse stock split of the company’s common stock. Additionally, the executive compensation plan was approved, the appointment of Machias Gini & O’Connell LLP as the independent accounting firm was ratified, and the possibility of adjourning the meeting due to insufficient proxies was sanctioned.
More about Entero Therapeutics
Average Trading Volume: 1,652,613
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.86M
Find detailed analytics on ENTO stock on TipRanks’ Stock Analysis page.